Clinical trials are crucial for drug development but often face uncertain outcomes due to safety, efficacy, or patient recruitment problems. In a scientific paper recently published in Cell Patterns, IQVIA experts Lucas Glass and Jimeng Sun proposed using a Hierarchical INTeraction network (HINT) to predict clinical trial outcomes.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
.svg){kind=icon}
